Literature DB >> 7877691

Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product.

A H Cavanaugh1, W M Hempel, L J Taylor, V Rogalsky, G Todorov, L I Rothblum.   

Abstract

The protein encoded by the retinoblastoma susceptibility gene (Rb) functions as a tumour suppressor and negative growth regulator. As actively growing cells require the ongoing synthesis of ribosomal RNA, we considered that Rb might interact with the ribosomal DNA transcription apparatus. Here we report that (1) there is an accumulation of Rb protein in the nucleoli of differentiated U937 cells which correlates with inhibition of rDNA transcription; (2) addition of Rb to an in vitro transcription system inhibits transcription by RNA polymerase I; (3) this inhibition requires a functional Rb pocket; and (4) Rb specifically inhibits the activity of the RNA polymerase I transcription factor UBF (upstream binding factor) in vitro. This last observation was confirmed by affinity chromatography and immunoprecipitation, which demonstrated an interaction between Rb and UBF. These results indicate that there is an additional mechanism by which Rb suppresses cell growth, namely that Rb directly represses transcription of the rRNA genes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7877691     DOI: 10.1038/374177a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  113 in total

1.  Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.

Authors:  F A Dick; E Sailhamer; N J Dyson
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Repression of ribosome and tRNA synthesis in secretion-defective cells is signaled by a novel branch of the cell integrity pathway.

Authors:  Y Li; R D Moir; I K Sethy-Coraci; J R Warner; I M Willis
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 3.  Survey and summary: transcription by RNA polymerases I and III.

Authors:  M R Paule; R J White
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

4.  DNA looping in the RNA polymerase I enhancesome is the result of non-cooperative in-phase bending by two UBF molecules.

Authors:  V Y Stefanovsky; G Pelletier; D P Bazett-Jones; C Crane-Robinson; T Moss
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

5.  Overlapping functions of the pRb family in the regulation of rRNA synthesis.

Authors:  S Ciarmatori; P H Scott; J E Sutcliffe; A McLees; H M Alzuherri; J H Dannenberg; H te Riele; I Grummt; R Voit; R J White
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition.

Authors:  D G Pestov; Z Strezoska; L F Lau
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

7.  The interferon-inducible nucleolar p204 protein binds the ribosomal RNA-specific UBF1 transcription factor and inhibits ribosomal RNA transcription.

Authors:  C J Liu; H Wang; P Lengyel
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

8.  The retinoblastoma tumor suppressor protein targets distinct general transcription factors to regulate RNA polymerase III gene expression.

Authors:  H A Hirsch; L Gu; R W Henry
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

9.  Retinoblastoma protein disrupts interactions required for RNA polymerase III transcription.

Authors:  J E Sutcliffe; T R Brown; S J Allison; P H Scott; R J White
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

10.  A targeting modality for destruction of RNA polymerase I that possesses anticancer activity.

Authors:  Karita Peltonen; Laureen Colis; Hester Liu; Rishi Trivedi; Michael S Moubarek; Henna M Moore; Baoyan Bai; Michelle A Rudek; Charles J Bieberich; Marikki Laiho
Journal:  Cancer Cell       Date:  2014-01-13       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.